Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | University Hospitals Birmingham NHS Foundation Trust |
| Main Category: | Services |
| Procurement Method: | Below threshold - without competition |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 13 February 2026 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-065372 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
Subcontract for the provision of care of patients being treated with Exagamglogene autotemcel (Exa-cel/Casgevy) for transfusion dependent β-thalassaemia or severe sickle cell disease UHB-SWBH Exa-cel subcontract 25/26
Published contracts in the last 12 months
280
total contracts
£269.4m
total value
£4,208,994
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Notice Reference: | 013225-2026 |